Location: Home > Pharma China Web Edition
  • search
  • go
  • Legal/IPR News
  • 2/21/2025Novo Nordisk Sues KBP Biosciences for $830 Million Over Alleged Fraud
  • 1/27/2025State Council Releases Final Antitrust Guidelines for the Pharmaceutic...
  • 1/11/2025Bayer Initiates Patent Infringement Lawsuit Against Hengrui Medicine i...
  • 12/10/2024Oxford Nanopore Sues Chinese Biotech Giant BGI Over Alleged Misuse of ...
  • 11/19/2024Congress Debates Biosecure Act Amid Report Highlighting Misaligned Foc...
  • 11/4/2024China Targets AstraZeneca in BMI Fraud Probe over Tagrisso
  • 10/30/2024AstraZeneca China President Under Investigation Amid Broader Scrutiny ...
  • 10/28/2024BeiGene Executive Under Investigation in China Amid Scrutiny of AstraZ...
  • 10/24/2024Rouse: China's Rapid Rise in Global Innovation Strengthens Patent Syst...
  • 10/8/2024Aadi Bio Wins Arbitration, Rejecting Multimillion-Dollar Claim from Ch...
  • 10/1/2024InventisBio Prevails in Trade Secret Misappropriation Lawsuit Filed by...
  • 9/9/2024House Passes BIOSECURE Act, Targeting Chinese Biotech Companies
  • 8/29/2024U.S. Government Funding Yields Over 1,000 Patents for China-Based Rese...
  • 8/21/2024Six Drug Cos Sanctioned for Bid-Rigging in China’s Centralized Drug P...
  • 8/21/2024Astellas Executive Indicted in China after Detention
  • 8/15/2024SAMR Releases Draft Pharma Anti-monopoly Guidelines
  • 6/26/2024Shanghai Claims IP Protection Advancement in Pharmaceutical Sector
  • 6/4/2024Genscript Denies Party Links
  • 5/31/2024U.S. Congress Seeks FBI Briefing on GenScript Over Potential Chinese I...
  • 5/1/2024PTAB to Hold Trial in Patent Dispute Involving BeiGene and AbbVie's Ph...
  • 4/18/2024Andao Pharma/Kind Pharma and Fibrogen Settle on IP Dispute over HIF- P...
  • Page:1/1 Total number of articles:21: [First][<<] [1] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group